查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995283

電腦輔助檢測市場：按組件、診斷成像、部署、應用和最終用戶分類－2026-2032年全球市場預測

Computer Aided Detection Market by Component, Imaging Modality, Deployment, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，電腦輔助偵測 (CAD) 市場價值將達到 9.7645 億美元，到 2026 年將成長至 10.3545 億美元，到 2032 年將達到 14.3396 億美元，複合年成長率為 5.64%。

主要市場統計數據
基準年 2025 9.7645億美元
預計年份：2026年 1,035,450,000 美元
預測年份：2032年 1,433,960,000 美元
複合年成長率 (%) 5.64%

本次演講將探討演算法檢測在臨床影像診斷中不斷演變的作用，並概述影響其在醫療保健服務各個方面實施的策略因素。

電腦輔助檢測已從實驗性輔助手段發展成為提高診斷效率和臨床決策支援的核心驅動力。過去十年間，醫學影像硬體和軟體演算法的進步共同推動了自動檢測從小眾研究工具發展成為診斷中心、醫院和實驗室的實用功能。隨著影像處理能力和影像方式的不斷提升，醫療服務提供者越來越依賴演算法輔助來縮短解讀時間、識別細微病變，並實現不同醫療機構間觀察解讀的標準化。

本文描述了正在重新定義檢測軟體如何融入臨床護理和採購的關鍵技術、監管和商業性轉折點。

電腦輔助檢測 (CAD) 領域正經歷變革，其驅動力包括技術成熟、醫療服務經濟模式的演變以及監管期望的轉變。首先，先進的深度學習演算法能夠對 CT 和 MRI 等複雜成像方式進行更精細的模式識別，同時也提高了胸部 X 光和超音波的穩健性。其次，關於部署模式的討論也正在轉變。雲端平台為回顧性訓練和前向推理提供了強大的運算能力，而混合部署和本地部署在資料主權和延遲限制至關重要的場景下仍然需求旺盛。

這解釋了近期關稅和貿易趨勢如何重塑採購邏輯、供應商策略以及對模組化、可互通解決方案的重視。

近期圍繞關稅和貿易措施的政策發展，為醫療影像硬體和計算基礎設施的採購和供應鏈規劃增添了新的變數。對於依賴進口影像檢測器、專用處理器或預先配置推理設備的系統而言，進口關稅的提高可能會增加總體擁有成本 (TCO) 並延長供應商的前置作業時間。因此，採購團隊正在重新評估供應商，更加重視模組化和在地採購選項，同時也在仔細審查服務合約中保護買方免受供應鏈波動影響的條款。

這揭示了部署模型、最終用戶概況、組件差異、成像方式和臨床應用如何共同決定開發和商業化的優先事項。

了解市場區隔有助於明確產品設計和商業化工作應如何與使用者需求和技術限制相符。部署選項分為兩大通路：雲端和本地部署。雲端服務又可細分為平台服務和軟體即服務 (SaaS) 模式。而本地部署系統則分為永久授權和訂閱模式。這種二分法顯然會導致使用者對維護、更新頻率和總生命週期成本的不同預期。最終使用者細分因診斷中心、醫院和實驗室而異，每個機構的工作流程量和檢驗要求各不相同。此外，醫院環境尤其關注腫瘤學和放射學的特殊性，這些領域需要精準的檢測能力以及與多學科工作流程的整合。

這清楚地解釋了美洲、歐洲、中東和非洲以及亞太地區在法規、採購和臨床實踐方面的地域差異如何影響商業化和部署選擇。

區域趨勢對部署模式、監管回應管道和商業策略有顯著影響。在美洲，醫療系統和私人影像網路傾向於快速部署檢驗的檢測工具，這些工具能夠提高工作流程效率並與電子健康記錄整合。同時，採購團隊會仔細評估與報銷管道和臨床醫生工作效率相關的價值提案。相較之下，歐洲、中東和非洲的監管環境則較為複雜，各國衛生機構的要求以及關於資料居住的法規都要求採用不同的市場進入模式。供應商通常會尋求與當地整合商建立策略合作夥伴關係，並將遵守區域臨床指南作為首要任務。

這概括了競爭格局，其中臨床檢驗、整合能力和卓越的服務是供應商的關鍵差異化因素，並決定了買家的選擇。

能夠展現臨床成效、強大的整合能力以及清晰的營運價值實現路徑的公司，才是推動競爭趨勢的關鍵。領先的供應商通常會將演算法方面的專業知識與和影像設備製造商、PACS供應商以及醫療IT整合商建立的牢固夥伴關係相結合，從而減少部署阻力。此外，提供部署支援、臨床醫生培訓和效能監控等服務的參與企業，透過確保持續的臨床部署和可衡量的工作流程改進，在初始授權合約之外，也能夠有效提升客戶留存率。

本指南為供應商和醫療機構提出了具體的策略重點，以加快部署速度，確保互通性，並展現永續的臨床和營運價值。

產業領導者應優先採取一系列切實可行的步驟，將證據轉化為實際應用和永續價值。首先，投資進行與支付方和醫療採購委員會關注的關鍵終點相符的、臨床嚴謹的檢驗研究，從而將技術性能轉化為可量化的臨床和營運效益。其次，採用模組化架構，使軟體能夠在雲端、混合環境和本地環境中運作，從而滿足不同客戶的需求，並降低供應鏈和關稅風險。

本文檔詳細介紹了一種透明的混合方法研究途徑，該方法整合了相關人員訪談、臨床文獻和產品文檔，確保建議以實際操作為基礎。

本研究途徑結合了多領域證據基礎和結構化定性分析，以得出可靠且可操作的結論。透過對醫療設備採購經理、放射科主任、放射技師和演算法開發人員的結構化訪談，我們獲得了關於實施重點、檢驗預期和營運挑戰的觀點。二次分析透過整合關於演算法性能和特定模式技術限制的同行評審文獻，並輔以監管指導文件和公開的臨床實驗室註冊信息，評估了證據的成熟度。

本文從整體觀點探討了臨床檢驗、互通性和適應性經營模式如何決定檢測解決方案的長期成功。

總之，電腦輔助檢測融合了演算法進步、臨床對可靠決策支援的需求以及以柔軟性和可驗證價值為優先的經營模式。成功實施取決於演算法的效能以及供應商能否將無縫整合、可重複的臨床證據和適應性強的部署方案相結合，同時兼顧當地的監管和採購實際情況。因此，決策者必須全面評估臨床有效性、部署柔軟性和上市後支持，以確保其持久有效性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：電腦輔助檢測市場：依組件分類

  • 硬體
  • 服務
  • 軟體

第9章：電腦輔助檢測市場：依影像方法分類

  • CT
  • MRI
  • PET
  • 超音波
  • X光

第10章：電腦輔助偵測市場：依部署方式分類

  • 雲
    • PaaS
    • SaaS
  • 現場
    • 永久許可
    • 訂閱

第11章：電腦輔助檢測市場：按應用領域分類

  • 胸部
  • 冒號
  • 肺
  • 攝護腺

第12章：電腦輔助偵測市場：依最終使用者分類

  • 診斷中心
  • 醫院
    • 腫瘤學
    • 放射科
  • 研究機構

第13章：電腦輔助偵測市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：電腦輔助檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 電腦輔助檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國電腦輔助檢測市場

第17章：中國的電腦輔助檢測市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, LLC
  • Hologic, Inc.
  • iCAD, Inc.
  • International Business Machines Corporation
  • Koninklijke Philips NV
  • Lunit Inc.
  • ScreenPoint Medical BV
  • Siemens Healthineers AG
  • Volpara Health Technologies Limited
Product Code: MRR-385067DD9C86

The Computer Aided Detection Market was valued at USD 976.45 million in 2025 and is projected to grow to USD 1,035.45 million in 2026, with a CAGR of 5.64%, reaching USD 1,433.96 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 976.45 million
Estimated Year [2026] USD 1,035.45 million
Forecast Year [2032] USD 1,433.96 million
CAGR (%) 5.64%

Introduce the evolving role of algorithmic detection in clinical imaging and outline strategic drivers shaping adoption across healthcare delivery settings

Computer aided detection has matured from an experimental adjunct to a central enabler of diagnostic efficiency and clinical decision support. Over the past decade, advances in medical imaging hardware and software algorithms have converged to elevate automated detection from a niche research tool into an operational capability across diagnostic centers, hospitals, and research laboratories. As imaging throughput and modality diversity expand, providers increasingly rely on algorithmic assistance to reduce reading times, flag subtle pathology, and standardize interpretation across distributed care settings.

This introduction frames the contemporary landscape in which deployment choices, clinical workflow integration, and regulatory acceptance determine the pace at which detection tools move from pilot to routine use. It also situates the reader to understand how infrastructure preferences-whether cloud platforms offering managed scalability or on-premise systems prioritizing data residency-shape procurement and vendor selection. By highlighting the interplay between algorithm evolution, imaging modality coverage, and clinical use cases from oncology to routine screening, the introduction orients decision-makers to the strategic levers that will drive adoption and sustained value realization.

Describe the pivotal technological, regulatory, and commercial inflection points that together are redefining how detection software integrates into clinical care and procurement

The landscape of computer aided detection is undergoing transformative shifts driven by technological maturation, changing care delivery economics, and evolving regulatory expectations. First, algorithmic sophistication has accelerated through deep learning, enabling more nuanced pattern recognition across complex modalities such as CT and MRI, while also improving robustness in chest radiography and ultrasound. Second, the deployment conversation has shifted: cloud platforms now promise elastic compute for retrospective training and prospective inference, while hybrid and on-premise deployments retain appeal where data sovereignty and latency constraints matter.

Concurrently, clinical adoption is being propelled by reimbursement and value arguments that tie detection performance to measurable workflow gains and patient outcomes. Radiology groups and oncology centers increasingly evaluate solutions on integration ease, interpretability, and ability to triage high-acuity cases. Finally, vendor strategies are consolidating around comprehensive product suites that couple imaging algorithms with clinical decision support and connectivity, reflecting a market that favors end-to-end solutions capable of embedding into electronic health records and PACS environments. Taken together, these shifts emphasize integration, clinical validation, and operational scalability as the primary determinants of success moving forward.

Explain how recent tariff influences and trade dynamics are reshaping procurement logic, vendor strategies, and the emphasis on modular, interoperable solutions

Recent policy actions around tariffs and trade measures have introduced new variables into procurement and supply chain planning for imaging hardware and compute infrastructure. For systems that rely on imported imaging detectors, specialized processors, or preconfigured inference appliances, increased import duties can raise total cost of ownership and extend vendor lead times. Consequently, procurement teams are recalibrating vendor evaluations to emphasize modularity and local sourcing options, while service agreements are being scrutinized for clauses that insulate buyers from supply chain volatility.

Beyond direct device costs, tariffs influence vendor pricing strategies and strategic localization decisions. Some vendors respond by diversifying manufacturing footprints or partnering with regional integrators to preserve price competitiveness and maintain service levels. Others accelerate software-only offerings that pivot away from bundled hardware sales, thereby minimizing exposure to cross-border levies. In parallel, users are prioritizing cloud-native deployments or subscription licensing that decouple licensing from hardware procurement cycles. The net effect is heightened attention to contractual flexibility and a renewed emphasis on interoperability, enabling healthcare providers to swap components without incurring prohibitive costs or losing clinical continuity.

Reveal how deployment models, end-user profiles, component distinctions, imaging modalities, and clinical applications together define development and commercialization priorities

Understanding segmentation illuminates where product design and commercialization efforts must align with user needs and technical constraints. Deployment choices split between cloud and on-premise pathways, with cloud offerings further differentiated by platform service and software as a service approaches, while on-premise systems distinguish between perpetual licensing and subscription models; this dichotomy drives distinct expectations around maintenance, update cadence, and total lifecycle costs. End-user segmentation spans diagnostic centers, hospitals, and research laboratories, each with differing workflow volumes and validation requirements, and within hospital settings there is a particular focus on oncology and radiology specialties that demand targeted detection capabilities and integration with multidisciplinary workflows.

Component segmentation separates hardware, services, and software, and within software the focus narrows to algorithmic performance where deep learning, traditional machine learning, and rule-based approaches offer different trade-offs in explainability, training data needs, and generalizability. Imaging modality segmentation highlights modality-specific requirements across CT, MRI, PET, ultrasound, and X-ray, where resolution, contrast mechanisms, and acquisition variability impose unique algorithm design and validation approaches. Finally, application segmentation that includes breast, colorectal, lung, and prostate detection underscores the clinical heterogeneity of use cases: screening programs emphasize sensitivity and throughput, while diagnostic workflows prioritize specificity and detailed lesion characterization. Taken together, these segment lenses guide where vendors should prioritize engineering effort, clinical evidence generation, and go-to-market narratives.

Articulate how geographic regulatory, procurement, and clinical practice differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape commercialization and deployment choices

Regional dynamics materially influence adoption patterns, regulatory pathways, and commercial tactics. In the Americas, health systems and private imaging networks tend to favor rapid adoption of validated detection tools that can demonstrate workflow efficiency and integration with electronic records, while procurement teams closely assess reimbursement pathways and value propositions tied to clinician productivity. In contrast, the Europe, Middle East & Africa region presents a heterogeneous regulatory landscape where national health authority requirements and data residency rules require nuanced market entry models; vendors often pursue strategic partnerships with local integrators and prioritize conformity with regional clinical guidelines.

The Asia-Pacific region combines high volume imaging demand with a mix of public and private delivery models, creating opportunities for scalable cloud deployments as well as locally hosted solutions to meet regulatory and infrastructure constraints. Across all regions, success hinges on tailoring validation studies to local patient populations, ensuring linguistic and workflow localization, and building services capabilities that support deployments at scale. Transitioning from pilot projects to enterprise-grade installations requires both technical adaptability and a deep understanding of each region's purchasing practices and clinical priorities.

Summarize the competitive landscape where clinical validation, integration prowess, and service excellence determine vendor differentiation and buyer selection

Competitive dynamics are anchored by companies that can demonstrate clinical validation, robust integration capabilities, and a clear pathway to operational value. Leading vendors often combine algorithmic expertise with strong partnerships across imaging hardware manufacturers, PACS vendors, and health IT integrators to reduce friction at deployment. Additionally, service-oriented players that offer implementation support, clinician training, and performance monitoring create stickiness beyond initial license agreements by ensuring sustained clinical adoption and measurable workflow improvements.

New entrants compete by focusing on niche applications or modality specialization, leveraging proprietary datasets and academic collaborations to build differentiated algorithms. At the same time, established imaging vendors and cloud providers leverage scale and platform capabilities to offer bundled solutions that appeal to enterprise buyers. Strategic alliances and acquisitions continue to shape the competitive field, as larger players seek to fill modality or application gaps while smaller firms pursue validation partnerships with leading clinical centers to build credibility. For buyers, vendor selection increasingly evaluates not only detection accuracy but also post-sales support, regulatory readiness, and the capacity to co-develop bespoke workflows.

Recommend concrete strategic priorities for vendors and provider organizations to accelerate adoption, ensure interoperability, and demonstrate enduring clinical and operational value

Industry leaders should prioritize a set of actionable moves that translate evidence into adoption and sustained value. First, invest in clinically rigorous validation studies that align with the endpoints that matter to payers and provider procurement committees, thereby converting technical performance into quantifiable clinical and operational benefits. Second, embrace modular architectures that allow software to operate across cloud, hybrid, and on-premise environments to meet diverse customer constraints and to mitigate supply chain and tariff exposure.

Third, develop robust partnership models with imaging hardware vendors, IT integrators, and clinical centers to accelerate deployments and reduce implementation risk. Fourth, design pricing and contracting approaches that reflect operational realities-such as subscription models tied to usage or outcome-based provisions-to lower adoption barriers. Finally, build post-deployment capabilities for performance monitoring, clinician feedback loops, and continuous learning to maintain algorithmic relevance and to demonstrate longitudinal value. By executing these recommendations, leaders can convert technical innovation into durable market advantage and deeper clinical integration.

Detail a transparent mixed methods research approach that integrates stakeholder interviews, clinical literature, and product documentation to ground recommendations in operational reality

The research approach combined a multi-disciplinary evidence base and a structured qualitative synthesis to ensure robust, actionable conclusions. Primary insights derived from structured interviews with device procurement leads, radiology chiefs, imaging technologists, and algorithm developers provided perspective on deployment preferences, validation expectations, and operational pain points. Secondary analysis integrated peer-reviewed literature on algorithm performance and modality-specific technical constraints, complemented by regulatory guidance documents and publicly available clinical trial registries to assess evidence maturity.

The methodology emphasized triangulation: vendor capability statements and product documentation were cross-checked against clinician feedback and case studies to reveal implementation gaps. Where appropriate, technical white papers and interoperability specifications were referenced to validate claims about integration and data handling. Throughout the research, attention centered on reproducibility and transparency, documenting inclusion criteria for interviewed stakeholders, the scope of modality and application coverage, and the limits of inference where public evidence was sparse. This mixed-methods approach ensured that recommendations reflect both operational realities and the state of scientific validation.

Conclude with an integrative perspective on how clinical validation, interoperability, and adaptive commercial models will determine long term success for detection solutions

In conclusion, computer aided detection is positioned at the confluence of algorithmic progress, clinical demand for reliable decision support, and shifting commercial models that prioritize flexibility and demonstrable value. Adoption will continue to hinge on the ability of vendors to pair algorithmic performance with seamless integration, reproducible clinical evidence, and adaptable deployment options that respect regional regulatory and procurement realities. Decision-makers should therefore evaluate solutions on a composite of clinical validity, deployment flexibility, and post-market support to ensure sustained impact.

Looking ahead, the vendors and providers that win will be those who translate technical accuracy into measurable improvements in workflow efficiency, diagnostic consistency, and patient outcomes, supported by pricing and contracting models that lower the threshold for adoption. By aligning product development with the nuanced needs of specialty users, imaging modalities, and regional healthcare systems, stakeholders can realize the promise of detection technologies and embed them as reliable components of modern diagnostic pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Computer Aided Detection Market, by Component

  • 8.1. Hardware
  • 8.2. Services
  • 8.3. Software

9. Computer Aided Detection Market, by Imaging Modality

  • 9.1. CT
  • 9.2. MRI
  • 9.3. PET
  • 9.4. Ultrasound
  • 9.5. X Ray

10. Computer Aided Detection Market, by Deployment

  • 10.1. Cloud
    • 10.1.1. Paas
    • 10.1.2. Saas
  • 10.2. On Premise
    • 10.2.1. Perpetual
    • 10.2.2. Subscription

11. Computer Aided Detection Market, by Application

  • 11.1. Breast Cancer
  • 11.2. Colorectal
  • 11.3. Lung
  • 11.4. Prostate

12. Computer Aided Detection Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Hospitals
    • 12.2.1. Oncology
    • 12.2.2. Radiology
  • 12.3. Research Labs

13. Computer Aided Detection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Computer Aided Detection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Computer Aided Detection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Computer Aided Detection Market

17. China Computer Aided Detection Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Fujifilm Holdings Corporation
  • 18.6. GE HealthCare Technologies, LLC
  • 18.7. Hologic, Inc.
  • 18.8. iCAD, Inc.
  • 18.9. International Business Machines Corporation
  • 18.10. Koninklijke Philips N.V.
  • 18.11. Lunit Inc.
  • 18.12. ScreenPoint Medical B.V.
  • 18.13. Siemens Healthineers AG
  • 18.14. Volpara Health Technologies Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPUTER AIDED DETECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COMPUTER AIDED DETECTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 165. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 166. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 167. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 191. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 193. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 194. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 201. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 202. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 203. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)